Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
Phase of Trial: Phase II/III
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Dolutegravir (Primary) ; Efavirenz; Lamivudine; Tenofovir
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms DOLPHIN-1
- 07 Mar 2018 Interim results presented at the 25th Conference on Retroviruses and Opportunistic Infections
- 14 Mar 2017 Planned End Date changed from 1 Nov 2016 to 1 Nov 2017.
- 14 Mar 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.